Picture of Davita logo

DVA — Davita News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapSuper Stock

DaVita Inc reports results for the quarter ended in June - Earnings Summary

* DaVita Inc  DVA.N  reported quarterly adjusted earnings of
$2.50​​ per share for the quarter ended in June, higher than the
same quarter last year, when the company reported EPS of $1.91. 
The mean expectation of six analysts for the quarter was
for earnings of $2.54 per share. Wall Street expected results to
range from $2.42  to $2.75 per share.
    * Revenue rose 6.2% to $3.19 billion from a year ago;
analysts
expected $3.15 billion. 
    * DaVita Inc's reported EPS for the quarter was $2.50​.
    * The company reported quarterly net income of $222.68
million.
    * DaVita Inc shares had fallen by 2.3% this quarter and
gained 29.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 2.5%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 6
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the healthcare
facilities & services peer group is also "hold"

Wall Street's median 12-month price target for DaVita Inc is
$150.00 
This summary was machine generated from LSEG data August 6 at
10:15 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      2.54           2.50           Missed
 Mar. 31 2024      1.95           2.26           Beat
 Dec. 31 2023      1.59           1.62           Beat
 Sep. 30 2023      2.02           2.62           Beat

Recent news on Davita

See all news